Home » Topics » Regulatory » Patents

Patents
RSS

Amgen discovers new beta-secretase inhibitors

July 10, 2018

New mutant EGFR inhibitors identified at Medshine Discovery

July 9, 2018

Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands

July 9, 2018

Hangzhou Innogate Pharma divulges protein kinase inhibitors

July 9, 2018

Leo Pharma presents phosphodiesterase PDE4 inhibitors

July 9, 2018

Fatty acid synthase inhibitors synthesized at Cephalon

July 9, 2018

mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical

July 9, 2018

Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists

July 6, 2018

Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer

July 6, 2018

Icahn School of Medicine at Mount Sinai discloses PROTAc compounds for cancer

July 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...